PATENT CLAIM ANALYSIS

Application Number: 16296766
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-07
Patent Classification: ["424", "130100"]

Abstract:
Compounds of formula (I): wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 12 , X, A and n are as defined in the description. Medicinal products containing the same which are useful in treating pathologies involving a deficit in apoptosis, such as cancer, auto-immune diseases, and diseases of the immune system.

Claim (Index 16):
The method according to  claim 15 , wherein Cy 1  represents heteroaryl.

Metadata:
- Claim Count in Document: 62.0
- Percentile: 99.0
- Lexical Diversity: 1.59574
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14576683', '15492306', '15738601', '16069891', '15737479']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8677326909025476
- 35 USC 102 Novelty (BERT): 0.683823403601865
- Combined Prediction Score: 0.8493417621724794
- Mean Citation Score: 685.7307800000002
- Max Citation Score: 719.5483
- Similarity Product: 687.2330328993141

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test